Jeffrey E. Russel

Array ( [id] => 3912680 [patent_doc_number] => 06001813 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Val-pro containing .alpha.-keto oxadiazoles as serine protease inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/090046 [patent_app_country] => US [patent_app_date] => 1998-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5506 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001813.pdf [firstpage_image] =>[orig_patent_app_number] => 090046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4105726 [patent_doc_number] => 06022722 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-08 [patent_title] => 'Renaturation of proteins' [patent_app_type] => 1 [patent_app_number] => 9/088058 [patent_app_country] => US [patent_app_date] => 1998-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 2793 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/022/06022722.pdf [firstpage_image] =>[orig_patent_app_number] => 088058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4187021 [patent_doc_number] => 06093696 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-25 [patent_title] => 'Tyrosine derivatives' [patent_app_type] => 1 [patent_app_number] => 9/086421 [patent_app_country] => US [patent_app_date] => 1998-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22843 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/093/06093696.pdf [firstpage_image] =>[orig_patent_app_number] => 086421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4260618 [patent_doc_number] => 06258782 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'Hybrid polypeptides with enhanced pharmacokinetic properties' [patent_app_type] => 1 [patent_app_number] => 9/082279 [patent_app_country] => US [patent_app_date] => 1998-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 26 [patent_no_of_words] => 142228 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258782.pdf [firstpage_image] =>[orig_patent_app_number] => 082279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4004122 [patent_doc_number] => 06004928 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-21 [patent_title] => 'Method of treating hyperlipidemia' [patent_app_type] => 1 [patent_app_number] => 9/078111 [patent_app_country] => US [patent_app_date] => 1998-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4352 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/004/06004928.pdf [firstpage_image] =>[orig_patent_app_number] => 078111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4207885 [patent_doc_number] => 06028054 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'Method for increasing bioavailability of oral pharmaceutical compositions' [patent_app_type] => 1 [patent_app_number] => 9/073704 [patent_app_country] => US [patent_app_date] => 1998-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12892 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 195 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/028/06028054.pdf [firstpage_image] =>[orig_patent_app_number] => 073704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3974035 [patent_doc_number] => 05948420 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-07 [patent_title] => 'Pharmaceutical and cosmetic compositions and their production' [patent_app_type] => 1 [patent_app_number] => 9/069973 [patent_app_country] => US [patent_app_date] => 1998-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3805 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/948/05948420.pdf [firstpage_image] =>[orig_patent_app_number] => 069973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4179345 [patent_doc_number] => 06037325 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase' [patent_app_type] => 1 [patent_app_number] => 9/069823 [patent_app_country] => US [patent_app_date] => 1998-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 25415 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 368 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/037/06037325.pdf [firstpage_image] =>[orig_patent_app_number] => 069823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4359287 [patent_doc_number] => 06191113 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-20 [patent_title] => 'Peptide for inhibiting growth of smooth muscle cells' [patent_app_type] => 1 [patent_app_number] => 9/051986 [patent_app_country] => US [patent_app_date] => 1998-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6567 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/191/06191113.pdf [firstpage_image] =>[orig_patent_app_number] => 051986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7625470 [patent_doc_number] => 06723699 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-20 [patent_title] => 'Treating disorders by application of insulin-like growth factors and analogs' [patent_app_type] => B1 [patent_app_number] => 09/064159 [patent_app_country] => US [patent_app_date] => 1998-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 20542 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/723/06723699.pdf [firstpage_image] =>[orig_patent_app_number] => 09064159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4207873 [patent_doc_number] => 06028053 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'Peptide inhibitors of a phosphotyrosine-binding domain containing protein' [patent_app_type] => 1 [patent_app_number] => 9/051934 [patent_app_country] => US [patent_app_date] => 1998-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 24 [patent_no_of_words] => 21612 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/028/06028053.pdf [firstpage_image] =>[orig_patent_app_number] => 051934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4087173 [patent_doc_number] => 06025401 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'Method and agents for inhibiting protein aging' [patent_app_type] => 1 [patent_app_number] => 9/062354 [patent_app_country] => US [patent_app_date] => 1998-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 17 [patent_no_of_words] => 11265 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025401.pdf [firstpage_image] =>[orig_patent_app_number] => 062354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3954761 [patent_doc_number] => 05935865 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-10 [patent_title] => 'Semaphorin gene family' [patent_app_type] => 1 [patent_app_number] => 9/060692 [patent_app_country] => US [patent_app_date] => 1998-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36634 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/935/05935865.pdf [firstpage_image] =>[orig_patent_app_number] => 060692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4067613 [patent_doc_number] => 05965118 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'Polymer-platinum compounds' [patent_app_type] => 1 [patent_app_number] => 9/060455 [patent_app_country] => US [patent_app_date] => 1998-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 23 [patent_no_of_words] => 12324 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965118.pdf [firstpage_image] =>[orig_patent_app_number] => 060455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4131646 [patent_doc_number] => 06034058 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Semi-synthetic alanyl dilemnin analogs' [patent_app_type] => 1 [patent_app_number] => 9/058508 [patent_app_country] => US [patent_app_date] => 1998-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4633 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/034/06034058.pdf [firstpage_image] =>[orig_patent_app_number] => 058508 [rel_patent_id] =>[rel_patent_doc_number] =>)